FDA Warning Letter — Xinxiang Tuoxin Pharmaceutical Co. Ltd

Case 494134 — FEI 3008259785

The FDA took a Warning Letter action against Xinxiang Tuoxin Pharmaceutical Co. Ltd on August 19, 2016 (Xinxiang, China). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
Xinxiang Tuoxin Pharmaceutical Co. Ltd
Date
August 19, 2016
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Xinxiang (China)